Breaking News

Catalent Grows Asia-Pacific Footprint

Invests $4.6mn to further expand clinical trials hub in Singapore

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalent Pharma Solutions said it is investing $4.6 million to further expand its Singapore clinical supply facility by building new flexible GMP space for secondary packaging, doubling its ambient storage space and quadrupling cold storage capacity. The continued expansion of the site will support global and regional customers’ growth in clinical trials activity in the Asia–Pacific region. Established in 1998, Catalent’s Singapore site now provides full clinical supply services including pro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters